{
  "trial_id": "NCT03360591",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Age > 18 years",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Written informed consent",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Diagnosis of severe native aortic valve disease with the indication to endovascular valve replacement given by Heart Team",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "valve replacement given by Heart Team",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Diagnosis of at least one coronary stenosis >50% at angiography",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "No specific pharmacologic treatment is required to enter the study",
      "label": "met",
      "evidence": ""
    }
  ],
  "exclusion": [
    {
      "criterion": "Age < 18 years",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Pregnancy",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Lack of informed consent",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Impaired left ventricular function",
      "label": "met",
      "evidence": ""
    },
    {
      "criterion": "Signs or symptoms of acute (unstable) myocardial ischemia",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Contraindication to adenosine administration (e.g., asthma, chronic obstructive pulmonary disease, heart rate <50 beats/min, and systolic blood pressure <90 mmHg)",
      "label": "not_met",
      "evidence": ""
    },
    {
      "criterion": "Reduced survival expectancy due to severe co-morbidities (<1 year)",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Impossibility to obtain follow-up information",
      "label": "unknown",
      "evidence": ""
    }
  ],
  "notes": "Patient has severe native aortic valve disease with indication for endovascular valve replacement, and no specific pharmacologic treatment is required. However, impaired left ventricular function may be a concern.",
  "_meta": {
    "topic_id": "2",
    "trial_id": "NCT03360591",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}